OCULAR THERAPEUTIX, INC (OCUL) Operating Income (Loss) USD 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Ocular Therapeutix, Inc quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2024.
  • Ocular Therapeutix, Inc Operating Income (Loss) for the quarter ending March 31, 2024 was -$31.6 M, a 40.2% decline year-over-year.
  • Ocular Therapeutix, Inc Operating Income (Loss) for the twelve months ending March 31, 2024 was -$91.5 M, a 9.69% decline year-over-year.
  • Ocular Therapeutix, Inc annual Operating Income (Loss) for 2023 was -$82.4 M, a 4.74% decline from 2022.
  • Ocular Therapeutix, Inc annual Operating Income (Loss) for 2022 was -$78.7 M, a 0.79% decline from 2021.
  • Ocular Therapeutix, Inc annual Operating Income (Loss) for 2021 was -$78 M, a 24.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$91.5 M -$31.6 M -$9.07 M -40.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$82.4 M -$20 M -$688 K -3.55% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 -$81.7 M -$19.2 M +$2.33 M +10.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$84 M -$20.6 M -$654 K -3.28% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 -$83.4 M -$22.5 M -$4.72 M -26.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$78.7 M -$19.4 M -$1.31 M -7.27% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 -$77.3 M -$21.5 M -$2.02 M -10.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$75.3 M -$19.9 M +$315 K +1.56% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$75.6 M -$17.8 M +$2.4 M +11.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$78 M -$18 M -$3.71 M -25.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-11
Q3 2021 -$74.3 M -$19.5 M -$5.52 M -39.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$68.8 M -$20.2 M -$2.35 M -13.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$66.5 M -$20.2 M -$3.61 M -21.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$62.8 M -$14.3 M +$7.06 M +33% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 -$69.9 M -$14 M +$9.14 M +39.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$79 M -$17.9 M +$3.72 M +17.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$82.8 M -$16.6 M +$3.04 M +15.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$85.8 M -$21.4 M -$4.12 M -23.8% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-12
Q3 2019 -$81.7 M -$23.1 M -$8.33 M -56.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$73.4 M -$21.6 M -$8.04 M -59.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 -$65.3 M -$19.7 M -$6.2 M -46.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$59.1 M -$17.3 M -$4.57 M -35.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$54.6 M -$14.8 M +$380 K +2.5% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-12
Q2 2018 -$54.9 M -$13.6 M +$4.78 M +26% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-12
Q1 2018 -$59.7 M -$13.5 M +$2.22 M +14.1% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-12
Q4 2017 -$61.9 M -$12.7 M -$244 K -1.96% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$61.7 M -$15.2 M -$5.96 M -64.5% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-07
Q2 2017 -$55.7 M -$18.3 M -$7.23 M -65.1% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-07
Q1 2017 -$48.5 M -$15.7 M -$5.16 M -49.1% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-07
Q4 2016 -$43.3 M -$12.5 M -$2.2 M -21.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$41.1 M -$9.24 M +$1.94 M +17.3% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-08
Q2 2016 -$43.1 M -$11.1 M -$1.47 M -15.3% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-08
Q1 2016 -$41.6 M -$10.5 M -$3.4 M -47.7% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-08
Q4 2015 -$38.2 M -$10.3 M -$2.73 M -36.1% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-10
Q3 2015 -$35.5 M -$11.2 M -$4.4 M -64.9% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-10
Q2 2015 -$31.1 M -$9.64 M -$3.69 M -62% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-10
Q1 2015 -$27.4 M -$7.11 M -$288 K -4.22% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-10
Q4 2014 -$27.1 M -$7.55 M -$4.13 M -121% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-10
Q3 2014 -$23 M -$6.78 M -$3.34 M -97.3% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-10
Q2 2014 -$19.6 M -$5.95 M -$2.96 M -98.9% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-10
Q1 2014 -$16.7 M -$6.83 M -$3.77 M -123% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-10
Q4 2013 -$12.9 M -$3.42 M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-20
Q3 2013 -$3.44 M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-20
Q2 2013 -$2.99 M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-20
Q1 2013 -$3.06 M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.